Back to Search
Start Over
Programmable Nuclease-Based Integration into Novel Extragenic Genomic Safe Harbor Identified from Korean Population-Based CNV Analysis
- Source :
- Molecular Therapy Oncolytics, Molecular Therapy: Oncolytics, Vol 14, Iss, Pp 253-265 (2019)
- Publication Year :
- 2019
- Publisher :
- American Society of Gene & Cell Therapy, 2019.
-
Abstract
- Here, we found two genomic safe harbor (GSH) candidates from chromosomes 3 and 8, based on large-scale population-based cohort data from 4,694 Koreans by CNV analysis. Furthermore, estimated genotype of these CNVRs was validated by quantitative real-time PCR, and epidemiological data examined no significant genetic association between diseases or traits and two CNVRs. After screening the GSH candidates by in silico approaches, we designed TALEN pairs to integrate EGFP expression cassette into human cell lines in order to confirm the functionality of GSH candidates in an in vitro setting. As a result, transgene insertion into one of the two loci using TALEN showed robust transgene expression comparable to that with an AAVS1 site without significantly perturbing neighboring genes. Changing the promoter or cell type did not noticeably disturb this trend. Thus, we could validate two CNVRs as a site for effective and safe transgene insertion in human cells. Keywords: genome editing, TALEN, safe harbor, copy number variation region
- Subjects :
- 0301 basic medicine
Cancer Research
Transgene
In silico
Population
Biology
lcsh:RC254-282
Article
03 medical and health sciences
0302 clinical medicine
TALEN
Genotype
copy number variation region
genome editing
Pharmacology (medical)
education
Gene
Genetic association
Genetics
Transcription activator-like effector nuclease
education.field_of_study
lcsh:Neoplasms. Tumors. Oncology. Including cancer and carcinogens
030104 developmental biology
Oncology
030220 oncology & carcinogenesis
Molecular Medicine
Expression cassette
safe harbor
Subjects
Details
- Language :
- English
- ISSN :
- 23727705
- Volume :
- 14
- Database :
- OpenAIRE
- Journal :
- Molecular Therapy Oncolytics
- Accession number :
- edsair.doi.dedup.....a67f93ce983394efd2d71ab1c1e5bb04